IMOPHORON LIMITED

Active Bristol

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

IMOPHORON LIMITED

Research and experimental development on biotechnology

Founded 5 Dec 2017 Active Bristol, England 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 18 Sept 2025 Next due 30 Sept 2025 9 months overdue
Confirmation Submitted 10 Dec 2024 Next due 18 Dec 2025 6 months overdue
Net assets £4 £1M 2024 year on year
Total assets £99K £1M 2024 year on year
Total Liabilities £99K £80K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Science Creates Old Market Midland Road Bristol BS2 0JZ England

Email

info@example.com

Website

www.example.com

Full company profile for IMOPHORON LIMITED (11096893), an active life sciences and medical technology company based in Bristol, England. Incorporated 5 Dec 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type micro-entity
Next accounts 31 Dec 2024
Due by 30 Sept 2025 9 months overdue

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

N/A

Net Assets

£4.00

Decreased by £1.07M (-100%)

Total Liabilities

£98.82k

Decreased by £80.46k (-45%)

Turnover

N/A

Employees

9

Decreased by 2 (-18%)

Debt Ratio

100%

Increased by 86 (+614%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Oct 2021Seed
Investor 2Oct 2021Seed
Investor 3Oct 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 3,302,729 Shares £5.67m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Dec 2024735,289£250k£0.34
27 Dec 2024735,294£250k£0.34
5 Apr 2023413,711£1.17m£2.82
6 Sept 20211,418,435£4.00m£2.82

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (18)

Octopus Titan Vct Plc
24.9%
Frederic Garzoni
19.3%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Imre Berger

Ceased 6 Sept 2021

Ceased

Frederic Garzoni

Ceased 6 Sept 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Sept 2025GazetteGazette Notice Voluntary
18 Sept 2025DissolutionDissolution Application Strike Off Company
18 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
11 Apr 2025OfficersTermination of Meagan Horton as director on 11 Apr 2025
17 Mar 2025CapitalAllotment of shares (GBP 474.1155) on 27 Dec 2024
30 Sept 2025 Gazette

Gazette Notice Voluntary

18 Sept 2025 Dissolution

Dissolution Application Strike Off Company

18 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

11 Apr 2025 Officers

Termination of Meagan Horton as director on 11 Apr 2025

17 Mar 2025 Capital

Allotment of shares (GBP 474.1155) on 27 Dec 2024

Recent Activity

Latest Activity

Gazette Notice Voluntary

8 months ago on 30 Sept 2025

Dissolution Application Strike Off Company

8 months ago on 18 Sept 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 18 Sept 2025

Termination of Meagan Horton as director on 11 Apr 2025

1 years ago on 11 Apr 2025

Allotment of shares (GBP 474.1155) on 27 Dec 2024

1 years ago on 17 Mar 2025